Trial Profile
A Randomized, Double-Blind, Multi-Center, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Oral Salmon Calcitonin in the Treatment of Subjects With Knee Osteoarthritis
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 01 Jan 2024
Price :
$35
*
At a glance
- Drugs Calcitonin (Primary)
- Indications Musculoskeletal pain; Osteoarthritis
- Focus Registrational; Therapeutic Use
- Acronyms OA 2 Study
- Sponsors Nordic Bioscience
- 15 Nov 2023 Results of post-hoc analysis of two studies (NCT00486434 and NCT00704847) assessing the effects of commonly used medications on changes in structural outcomes and WOMAC pain over a two-year period, presented at the ACR Convergence 2023.
- 03 Jun 2023 Results of post-hoc analysis assessing the impact of common demographic and pain characteristics on the SD of mean pain change from baseline in a large interventional OA trial database, presented at the 24th Annual Congress of the European League Against Rheumatism.
- 04 Jun 2022 Results of post-hoc analysis of two studies (NCT00486434 and NCT00704847) assessing antihistamine use during a two-year trial period and differences in structural progression, presented at the 23rd Annual Congress of the European League Against Rheumatism.